검색어 : 통합검색[Cheng Ian]
총 1,725건 중 1,000건 출력
, 24/100 페이지
-
231
- Stepwise Lateral Extension of Phenyl‐Substituted Linear Polyphenylenes
- Hou, Ian Cheng‐ Yi; Narita, Akimitsu; Mü llen, Klaus; ; (Macromolecular chemistry and physics, v.221, 2020, pp.2070001)
-
232
- Missing momentum reconstruction and spin measurements at hadron colliders
- Cheng, Hsin-Chia; Han, Zhenyu; Kim, Ian-Woo; Wang, Lian-Tao; ; (Journal of high energy physics : JHEP, v.2010, 2010, pp.122)
-
233
- Pulmonary carcinoids. Immunohistochemical demonstration of brain-gut peptides
- Yang, Kan; Ulich, Thomas; Taylor, Ian; Cheng, Lorna; Lewin, Klaus J.; ; (Cancer, v.52, 1983, pp.819-823)
-
234
- Divided Attention Alters Trailing Limb Stepping activity- A Dual-task Study
- Cheng, Kai; MILES, DAVID; Winchester, Ian; Clarke, Joel; Huang, Chun-Kai; ; (Archives of physical medicine and rehabilitation, v.103, 2022, pp.e126)
-
235
- Identifying the Satisfactions Derived from Leisure Gardening by Older Adults
- Cheng, Eva Hui‐ Ping; Patterson, Ian; Packer, Jan; Pegg, Shane; ; (Annals of leisure research, v.13, 2010, pp.395-419)
-
236
- Influence of DOC on MS-2 Bacteriophage Transport in a Sandy Soil
- Cheng, Li; Chetochine, Alexandra S.; Pepper, Ian L.; Brusseau, Mark L.; ; (Water, air, and soil pollution, v.178, 2007, pp.315-322)
-
237
- Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways
- Johnson, Brandon; Cheng, Lihong; Koenitzer, Jennifer; Catlett, Ian M.; Schafer, Peter; ; (Frontiers in immunology, v.15, 2024, pp.1437512)
-
238
- Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation
- Cheng, Fan; McLaughlin, Patricia J.; Banks, William A.; Zagon, Ian S.; ; (American journal of physiology. Regulatory, integrative and comparative physiology, v.297, 2009, pp.R844-R852)
-
239
- Buried Bumper Syndrome: a rare complication during radical chemoradiotherapy for head and neck cancer
- Teo, Rachel Pei Jing; Maniam, Akash; Boon, Ian; Boon, Cheng S; ; (BMJ case reports, v.14, 2021, pp.e238203)
-
240
- Abstract PD10-02: Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel + trastuzumab (TH) (ATEMPT) trial (TBCRC 033)
- Partridge, Ann; Zheng, Yue; Rosenberg, Shoshana; Gelber, Richard; Gelber, Shari; Barry, William; Dang, Chau; Yardley, Denise; Isakoff, Steven; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Weckstein, Douglas; Wolff, Antonio; Reeder-Hayes, Katherine; Rugo, Hope; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna; Constantine, Michael; Cheng, Kit; Briccetti, Frederick; Schneider, Bryan; Garrett, Merrill; Marcom, P. Kelly; Albain, Kathy; Defusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel; DeMeo, Michelle; Burstein, Harold; Winer, Eric P.; Krop, Ian; Tolaney, Sara; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.PD10-02-PD10-02)
QUICK MENU
